|
TMCO7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.725400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.019810E-01 |
| Normal-vs-Stage2 |
7.412100E-02 |
| Normal-vs-Stage3 |
7.055200E-03 |
| Normal-vs-Stage4 |
2.378300E-03 |
| Stage1-vs-Stage2 |
3.542700E-03 |
| Stage1-vs-Stage3 |
1.98764999999046E-05 |
| Stage1-vs-Stage4 |
1.55718999998999E-05 |
| Stage2-vs-Stage3 |
7.632600E-01 |
| Stage2-vs-Stage4 |
4.599400E-01 |
| Stage3-vs-Stage4 |
6.005000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.448000E-01 |
| Normal-vs-AfricanAmerican |
1.588260E-02 |
| Normal-vs-Asian |
6.830800E-01 |
| Caucasian-vs-AfricanAmerican |
5.045600E-02 |
| Caucasian-vs-Asian |
5.045200E-01 |
| AfricanAmerican-vs-Asian |
1.473560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.139620E-01 |
| Normal-vs-Female |
9.939200E-01 |
| Male-vs-Female |
1.242160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.173600E-02 |
| Normal-vs-Age(41-60Yrs) |
9.080600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.003640E-01 |
| Normal-vs-Age(81-100Yrs) |
7.747400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.769600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.491200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.809220E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.150180E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.460000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.258800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.984200E-02 |
| Normal-vs-Grade 2 |
6.936000E-01 |
| Normal-vs-Grade 3 |
3.753800E-01 |
| Normal-vs-Grade 4 |
1.69980999999986E-05 |
| Grade 1-vs-Grade 2 |
9.941000E-03 |
| Grade 1-vs-Grade 3 |
6.576200E-03 |
| Grade 1-vs-Grade 4 |
1.64977999999039E-05 |
| Grade 2-vs-Grade 3 |
1.849410E-01 |
| Grade 2-vs-Grade 4 |
6.78349999949646E-07 |
| Grade 3-vs-Grade 4 |
5.221000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.298160E-03 |
| Normal-vs-ccB subtype |
3.991300E-04 |
| ccA subtype-vs-ccB subtype |
1.07990283382264E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.136200E-01 |
| Normal-vs-N1 |
1.567390E-01 |
| N0-vs-N1 |
1.379030E-01 |
|
|
